Anika Therapeutics (ANIK) Treasury Shares (2016 - 2025)
Historic Treasury Shares for Anika Therapeutics (ANIK) over the last 16 years, with Q2 2025 value amounting to $957338.0.
- Anika Therapeutics' Treasury Shares rose 170629.81% to $957338.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $957338.0, marking a year-over-year increase of 170629.81%. This contributed to the annual value of $836562.0 for FY2024, which is 845.31% up from last year.
- Latest data reveals that Anika Therapeutics reported Treasury Shares of $957338.0 as of Q2 2025, which was up 170629.81% from $970830.0 recorded in Q1 2025.
- Anika Therapeutics' Treasury Shares' 5-year high stood at $970830.0 during Q1 2025, with a 5-year trough of $53000.0 in Q2 2024.
- In the last 5 years, Anika Therapeutics' Treasury Shares had a median value of $745872.5 in 2022 and averaged $669097.8.
- Per our database at Business Quant, Anika Therapeutics' Treasury Shares crashed by 9356.34% in 2024 and then surged by 170629.81% in 2025.
- Over the past 5 years, Anika Therapeutics' Treasury Shares (Quarter) stood at $412658.0 in 2021, then surged by 63.67% to $675405.0 in 2022, then rose by 14.21% to $771358.0 in 2023, then rose by 8.45% to $836562.0 in 2024, then grew by 14.44% to $957338.0 in 2025.
- Its Treasury Shares was $957338.0 in Q2 2025, compared to $970830.0 in Q1 2025 and $836562.0 in Q4 2024.